CRIS Current Research Information System

BARBARA, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 18.203
NA - Nord America 18.167
EU - Europa 15.094
AF - Africa 1.102
SA - Sud America 1.089
OC - Oceania 55
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 53.713
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.916
IT - Italia 5.135
CN - Cina 4.815
SG - Singapore 4.734
VN - Vietnam 4.617
GB - Regno Unito 2.836
DE - Germania 1.635
HK - Hong Kong 1.450
SE - Svezia 995
FR - Francia 817
IN - India 813
BR - Brasile 771
UA - Ucraina 681
RU - Federazione Russa 625
KR - Corea 502
NL - Olanda 441
IE - Irlanda 440
FI - Finlandia 419
JP - Giappone 321
ZA - Sudafrica 272
CH - Svizzera 265
CI - Costa d'Avorio 255
EE - Estonia 181
TG - Togo 158
NG - Nigeria 153
PH - Filippine 129
AR - Argentina 127
CA - Canada 115
JO - Giordania 113
SC - Seychelles 112
AT - Austria 110
ID - Indonesia 103
TH - Thailandia 97
BD - Bangladesh 85
BG - Bulgaria 85
BE - Belgio 80
MX - Messico 77
ES - Italia 67
PL - Polonia 66
TR - Turchia 62
EC - Ecuador 56
TW - Taiwan 53
IQ - Iraq 50
PK - Pakistan 47
AU - Australia 43
CO - Colombia 42
GR - Grecia 41
IR - Iran 40
MA - Marocco 34
CL - Cile 32
UZ - Uzbekistan 29
CD - Congo 28
SA - Arabia Saudita 28
HR - Croazia 24
PT - Portogallo 24
PY - Paraguay 24
RO - Romania 23
MY - Malesia 21
CZ - Repubblica Ceca 20
EG - Egitto 18
AL - Albania 17
TN - Tunisia 16
LT - Lituania 13
DZ - Algeria 12
LB - Libano 12
VE - Venezuela 11
ET - Etiopia 10
NZ - Nuova Zelanda 10
UY - Uruguay 10
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 9
SK - Slovacchia (Repubblica Slovacca) 9
IL - Israele 8
KE - Kenya 8
KZ - Kazakistan 8
PE - Perù 8
BO - Bolivia 7
BY - Bielorussia 7
DO - Repubblica Dominicana 7
GT - Guatemala 7
HN - Honduras 7
HU - Ungheria 7
NP - Nepal 7
CR - Costa Rica 6
DK - Danimarca 6
KG - Kirghizistan 6
NI - Nicaragua 6
OM - Oman 6
AM - Armenia 5
KH - Cambogia 5
LV - Lettonia 5
SV - El Salvador 5
GA - Gabon 4
GH - Ghana 4
KW - Kuwait 4
MT - Malta 4
RS - Serbia 4
TT - Trinidad e Tobago 4
BA - Bosnia-Erzegovina 3
BB - Barbados 3
Totale 53.651
Salva come PNG Salva come JPEG
Città #
Singapore 3.222
Southend 2.422
Houston 2.131
Ashburn 1.681
Fairfield 1.471
Hong Kong 1.343
Hefei 1.059
Ho Chi Minh City 1.009
San Jose 986
Hanoi 893
Chandler 842
Santa Clara 682
Dong Ket 680
Bologna 676
Woodbridge 675
Wilmington 631
Seattle 617
Beijing 569
Princeton 526
Milan 522
Ann Arbor 471
Cambridge 471
Seoul 446
Dublin 432
Boardman 419
Rome 386
Jacksonville 382
Helsinki 323
Lauterbourg 322
Los Angeles 311
Munich 279
Tokyo 270
New York 257
Abidjan 255
Padova 237
Nanjing 231
Westminster 219
Bern 206
Dallas 198
Council Bluffs 184
Florence 170
Berlin 166
Lomé 158
Buffalo 154
Frankfurt am Main 147
Da Nang 143
Haiphong 143
Jinan 130
Guangzhou 117
Turin 117
Bengaluru 115
Naples 111
Amman 110
Abeokuta 109
San Diego 105
Shenyang 103
Shanghai 101
Saint Petersburg 100
Redondo Beach 96
Changsha 88
Brescia 85
São Paulo 84
Sofia 81
Johannesburg 80
Bremen 78
Mülheim 77
Tianjin 76
Orem 71
Medford 70
Vienna 70
Dearborn 64
Hebei 64
Nanchang 62
Falls Church 59
Chicago 56
Parma 55
Amsterdam 54
Hyderabad 54
Palermo 52
Hải Dương 51
Zhengzhou 51
Phoenix 50
Des Moines 49
Verona 49
Brussels 48
Hangzhou 47
Jakarta 47
Lappeenranta 47
Yubileyny 46
Falkenstein 45
London 45
Nuremberg 45
Jiaxing 44
Biên Hòa 42
Mahé 42
Washington 42
Bari 41
Bangkok 40
Shenzhen 40
Montreal 38
Totale 33.660
Salva come PNG Salva come JPEG
Nome #
New pathophysiological mechanisms in irritable bowel syndrome. 1.815
Italian guidelines for the management of irritable bowel syndrome: Joint Consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), General Medicine (SIMG), Gastroenterology, Hepatology and Pediatric Nutrition (SIGENP) and Pediatrics (SIP) 1.468
Interazioni tra sistema serotoninergico e mediatori dell'infiammazione nella fisiopatologia della sindrome dell'intestino irritabile 753
Seasonal pattern of peptic ulcer hospitalizations: analysis of the hospital discharge data of the Emilia-Romagna region of Italy. 552
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 342
La sindrome dell'intestino irritabile. 331
5-oxoETE triggers nociception in constipation-predominant irritable bowel syndrome through MAS-related G protein–coupled receptor D 319
Randomised controlled trial of mesalazine in IBS 316
Escherichia coli Nissle 1917 restores epithelial permeability alterations induced by irritable bowel syndrome mediators 312
Salmonella gastroenteritis during childhood is a risk factor for irritable bowel syndrome in adulthood 311
Management of Irritable Bowel Syndrome With Diarrhea 309
Chronic intestinal pseudo-obstruction related to viral infections. 301
Il sistema nervoso enterico. 289
METODO E KIT PER LA DIAGNOSI DELLA SENSIBILITA’ AL GLUTINE NON ASSOCIATA ALLA CELIACHIA 280
Collinsella aerofaciens as a predictive marker of response to probiotic treatment in non-constipated irritable bowel syndrome 274
[Some practical questions on chronic stipsis treatment with prucalopride] 264
Abnormalities of somatic peptide-containing nerves supplying the pelvic floor of women with genitourinary prolapse and stress urinary incontinence. 258
Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons 251
Use of macrogol 4000 in chronic constipation. 241
Diagnosis and therapy of irritable bowel syndrome 240
Sigmoid compliance and visceral perception in spinal cord injury patients 240
Anti-ganglioside antibodies in coeliac disease with neurological disorders. 239
Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. 236
Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome 235
A-Transducin, a Signaling Molecule of the Chemoreceptive Cascade, Is Expressed in Endocrine and Non-Endocrine Cells of the Pig Gastrointestinal Mucosa 234
Advancements in drug development for diarrhea-predominant irritable bowel syndrome 229
A novel locus for syndromic chronic idiopathic intestinal pseudo-obstruction maps to chromosome 8q23-q24. 229
beta3-adrenoceptors in the gut: evidence for a possible role in enteric neuroimmunomodulation 226
Chronic intestinal pseudo-obstruction: manifestations, natural history and management. 224
Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome 223
New insights into irritable bowel syndrome pathophysiological mechanisms: contribution of epigenetics 221
Lactiplantibacillus plantarum (CECT7484 and CECT7485) and Pedioccoccus acidilactici (CECT7483) enhance actin cytoskeleton and CYP1A1 expression restoring epithelial permeability alterations induced by irritable bowel syndrome mediators 220
Chemosensitività intestinale, nervi, cellule enteroendocrine, recettori del gusto 215
CLINICAL AND NEUROCHEMICAL FEATURES OF CHRONIC CONSTIPATION IN PATIENTS WITH PARKINSON DISEASE 215
The immune system in irritable bowel syndrome. 215
X Congresso Nazionale delle Malattie Digestive AIGO-SIED-SIGE. 214
Aminosalicylates and other anti-inflammatory compounds for irritable bowel syndrome. 213
Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome. 212
Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial 212
Animal models of chemically induced intestinal inflammation: Predictivity and ethical issues 210
Sarcopenia evaluated by EASL/AASLD computed tomography-based criteria predicts mortality in patients with cirrhosis: A systematic review and meta-analysis 208
New insights into human enteric neuropathies. 205
Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier 205
Chronic intestinal pseudo-obstruction. 204
MALATTIA DA REFLUSSO GASTROESOFAGEO 201
Serum zonulin and its diagnostic performance in non-coeliac gluten sensitivity 200
Geraniol Treatment for Irritable Bowel Syndrome: A Double-Blind Randomized Clinical Trial 199
Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease 197
JC virus infects the enteric glia of patients with chronic idiopathic intestinal pseudo-obstruction. 196
Colonic immune cells in irritable bowel syndrome: A systematic review and meta-analysis 196
Mutations in RAD21 Disrupt Regulation of APOB in Patients With Chronic Intestinal Pseudo-Obstruction. 195
Altered Serotonin Signaling and Extrinsic Sensory Neuron Activation in Irritable Bowel Syndrome 195
Neuropathological analisys and clinical correlates of chronic constipation in patients with parkinson’s disease 194
H 2breath testing for other gas-related syndromes 193
A global perspective on irritable bowel syndrome: a consensus statement of the World Gastroenterology Organisation Summit Task Force on irritable bowel syndrome 192
Expression and regulation of α-transducin in the pig gastrointestinal tract 191
Neuroimmune interactions at different intestinal sites are related to abdominal pain symptoms in children with IBS 189
Elucidating the gut microbiome of ulcerative colitis: bifidobacteria as novel microbial biomarkers 188
Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome 187
Quantification and Potential Functions of Endogenous Agonists of Transient Receptor Potential Channels in Patients With Irritable Bowel Syndrome 187
Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. 187
Diagnostic challenges of symptomatic uncomplicated diverticular disease 187
International consensus statement on microbiome testing in clinical practice 186
Non-celiac gluten sensitivity in the context of functional gastrointestinal disorders 186
Neuroplasticity of the enteric nervous system induced by inflammatory conditions in the gut 185
A new reliable method for evaluating gallbladder dynamics the 3-dimensional sonographic examination 183
Almost all irritable bowel syndromes are post-infectious and respond to probiotics: controversial issues. 182
Pathophysiology of Diverticular Disease: From Diverticula Formation to Symptom Generation 181
Changes of α-transducin immunoreactivity (IR) in the pig gastrointestinal (GI) mucosa evoked by fasting/refeeding. 181
Gut microbiota and related diseases: clinical features. 180
Paraneoplastic Syndrome 179
Pancreatic involvement in systemic sarcoidosis. A case report. 179
Gastroesophageal reflux disease: clinical and pathophysiological features (part I)] 179
Caratterizzazione genetico-molecolare e morfologica di un modello sperimentale di megacolon congenito non agangliare. 179
Evidence of RET/GDNF-related apolipoprotein B (APOB) activation and altered expression in patients with chronic intestinal pseudo-obstruction (CIPO) 179
Interferon-γ is increased in the gut of patients with irritable bowel syndrome and modulates serotonin metabolism 179
null 179
A mediator cocktail released from mucosal biopsies of IBS patients excites human and guinea pig enteric neurons. 178
Expression of alpha-transducin, a chemoreceptive molecule, in endocrine and non-endocrine cells of the pig gastrointestinal tract 178
Functional variants in the sucrase-isomaltase gene associate with increased risk of irritable bowel syndrome 178
Molecular Mechanisms Underlying Loss of Vascular and Epithelial Integrity in Irritable Bowel Syndrome 177
Gastroesophageal reflux disease: therapeutic features (Part II)] 177
Post-infectious Irritable Bowel Syndrome. 177
Fecal Clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome 177
5-HT7 Receptors Modulate Peristalsis and Accommodation in the Guinea Pig Ileum 176
Post COVID-19 irritable bowel syndrome 175
Chronic intestinal pseudo-obstruction: clinical features, diagnosis, and therapy. 175
Aspetti clinici ed anticorpi anti-neurone nella malattia celiaca con disordini neurologici 175
Gastro-oesophageal reflux and interstitial lung disease. 173
Glioplasticity in irritable bowel syndrome 172
Interactions between commensal bacteria and gut sensorimotor function in health and disease. 171
Serine proteases: new players in diarrhoea-predominant irritable bowel syndrome 171
Sensorineural hearing loss and celiac disease: a coincidental finding 171
Survival After Transarterial Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: An Updated Meta-analysis and Meta-regression 170
Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference 170
Enteric neuroplasticity evoked by inflammation 170
Neuroplasticità gastroenterica: dai geni all’infiammazione. 169
Clinical approach to diarrhea 168
An interdisciplinary approach to investigate the English spotting locus and its association with megacolon in the domestic rabbit: a new putative model of enteric neuronal dysfunction 168
Unsolved problems in the management of patients with gastro-oesophageal reflux disease 167
Totale 24.684
Salva come PNG Salva come JPEG
Categoria #
all - tutte 138.935
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 138.935
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.561 0 0 0 0 0 0 0 0 0 274 178 1.109
2021/20225.375 526 174 269 250 400 276 141 297 189 243 1.840 770
2022/20235.221 498 718 318 601 338 352 173 373 881 197 386 386
2023/20242.583 136 280 190 198 265 492 143 160 104 231 198 186
2024/20258.919 408 1.095 805 655 1.282 529 759 462 333 513 622 1.456
2025/202619.042 1.562 2.128 1.938 1.622 1.967 1.079 2.594 852 4.064 1.236 0 0
Totale 54.661